Positive CHMP opinion is based on results from the pivotal Phase II KarMMa study
News
Scientists identify link between genetic changes and rare childhood cancer rhabdomyosarcoma
Genetic changes could be used to guide treatment for the rare and aggressive cancer type
Over two million people may have had long COVID in England
Study of self-reported data found a sizeable portion of individuals reporting persistent COVID-19 symptoms
Blood test can detect more than 50 types of cancer
Findings of the latest study assessing the test back its use as a screening tool, researchers say
Sanofi, Regeneron’s Libtayo cleared for basal cell carcinoma
Libtayo is the first immunotherapy indicated for patients with advanced basal cell carcinoma
PharmaTimes announce partnership for the Communications Awards Charity Challenge
PharmaTimes are proud to confirm that we will be partnering with the Meningitis Research Foundation for the 2021 Communications Awards Charity Challenge.
‘What’s next for patient advocacy?’ Senior leader speakers for Patient Partnership Index event announced
‘What’s next for patient advocacy?’ will take place on Tuesday 6th July at 8.30am
Lecanemab wins breakthrough therapy designation in Alzheimer’s disease
Designation is based on data from a Phase IIb study including 856 patients with mild Alzheimer’s disease
Novartis announces digital collaboration with Hewlett Packard Enterprise
Collaboration aims to accelerate Novartis’ use of data and digital technologies
Arcus, Gilead prep Phase III studies of anti-TIGIT domvanalimab
Preparations come on the heels of positive results from the Phase II ARC-7 study
‘New’ GSK spotlights growth potential of vaccines and speciality medicines
British drugmaker predicted a substantial £33bn sales ambition by 2031 in investor update
Novartis reveals long-term results for MS therapy Kesimpta
B-cell targeting therapy preserved patients’ IgG/IgM levels, with no increased risk of serious infections
Cancer Research UK partners with Aleta Biotherapeutics on blood cancer therapy
Partnership will advance the early clinical development of CAR-T cell engager candidate ALETA-001
NHSX sets out new ‘patient-centred’ data strategy
Strategy includes proposals for patients to easily access their test results, medication lists, procedures and care plans
Gov’t injects £64m into clinical research plan
Funding will go toward the first phase of activity of ‘The Future of UK Clinical Research Delivery’ plan
